These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
780 related articles for article (PubMed ID: 25271725)
1. The contributory role of gut microbiota in cardiovascular disease. Tang WH; Hazen SL J Clin Invest; 2014 Oct; 124(10):4204-11. PubMed ID: 25271725 [TBL] [Abstract][Full Text] [Related]
2. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk. Zhu W; Buffa JA; Wang Z; Warrier M; Schugar R; Shih DM; Gupta N; Gregory JC; Org E; Fu X; Li L; DiDonato JA; Lusis AJ; Brown JM; Hazen SL J Thromb Haemost; 2018 Sep; 16(9):1857-1872. PubMed ID: 29981269 [TBL] [Abstract][Full Text] [Related]
3. Gut microbiota metabolism of L-carnitine and cardiovascular risk. Ussher JR; Lopaschuk GD; Arduini A Atherosclerosis; 2013 Dec; 231(2):456-61. PubMed ID: 24267266 [TBL] [Abstract][Full Text] [Related]
4. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Koeth RA; Wang Z; Levison BS; Buffa JA; Org E; Sheehy BT; Britt EB; Fu X; Wu Y; Li L; Smith JD; DiDonato JA; Chen J; Li H; Wu GD; Lewis JD; Warrier M; Brown JM; Krauss RM; Tang WH; Bushman FD; Lusis AJ; Hazen SL Nat Med; 2013 May; 19(5):576-85. PubMed ID: 23563705 [TBL] [Abstract][Full Text] [Related]
5. Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes Pathogenesis. Li D; Kirsop J; Tang WH Curr Diab Rep; 2015 Sep; 15(9):63. PubMed ID: 26208694 [TBL] [Abstract][Full Text] [Related]
6. Dioxin-like pollutants increase hepatic flavin containing monooxygenase (FMO3) expression to promote synthesis of the pro-atherogenic nutrient biomarker trimethylamine N-oxide from dietary precursors. Petriello MC; Hoffman JB; Sunkara M; Wahlang B; Perkins JT; Morris AJ; Hennig B J Nutr Biochem; 2016 Jul; 33():145-53. PubMed ID: 27155921 [TBL] [Abstract][Full Text] [Related]
7. Gut microbiota-derived trimethylamine-N-oxide: A bridge between dietary fatty acid and cardiovascular disease? He M; Tan CP; Xu YJ; Liu Y Food Res Int; 2020 Dec; 138(Pt B):109812. PubMed ID: 33288187 [TBL] [Abstract][Full Text] [Related]
8. Deficiency of PSRC1 accelerates atherosclerosis by increasing TMAO production via manipulating gut microbiota and flavin monooxygenase 3. Luo T; Guo Z; Liu D; Guo Z; Wu Q; Li Q; Lin R; Chen P; Ou C; Chen M Gut Microbes; 2022; 14(1):2077602. PubMed ID: 35613310 [TBL] [Abstract][Full Text] [Related]
9. Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far? Coutinho-Wolino KS; de F Cardozo LFM; de Oliveira Leal V; Mafra D; Stockler-Pinto MB Eur J Nutr; 2021 Oct; 60(7):3567-3584. PubMed ID: 33533968 [TBL] [Abstract][Full Text] [Related]
10. The use of an in-vitro batch fermentation (human colon) model for investigating mechanisms of TMA production from choline, L-carnitine and related precursors by the human gut microbiota. Day-Walsh P; Shehata E; Saha S; Savva GM; Nemeckova B; Speranza J; Kellingray L; Narbad A; Kroon PA Eur J Nutr; 2021 Oct; 60(7):3987-3999. PubMed ID: 33934200 [TBL] [Abstract][Full Text] [Related]
11. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery. Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744 [TBL] [Abstract][Full Text] [Related]
12. l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans. Koeth RA; Lam-Galvez BR; Kirsop J; Wang Z; Levison BS; Gu X; Copeland MF; Bartlett D; Cody DB; Dai HJ; Culley MK; Li XS; Fu X; Wu Y; Li L; DiDonato JA; Tang WHW; Garcia-Garcia JC; Hazen SL J Clin Invest; 2019 Jan; 129(1):373-387. PubMed ID: 30530985 [TBL] [Abstract][Full Text] [Related]
13. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. Romano KA; Vivas EI; Amador-Noguez D; Rey FE mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704 [TBL] [Abstract][Full Text] [Related]
15. Metaorganismal nutrient metabolism as a basis of cardiovascular disease. Brown JM; Hazen SL Curr Opin Lipidol; 2014 Feb; 25(1):48-53. PubMed ID: 24362355 [TBL] [Abstract][Full Text] [Related]
16. Trimethylamine/Trimethylamine-N-Oxide as a Key Between Diet and Cardiovascular Diseases. He S; Jiang H; Zhuo C; Jiang W Cardiovasc Toxicol; 2021 Aug; 21(8):593-604. PubMed ID: 34003426 [TBL] [Abstract][Full Text] [Related]
17. Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation. Kuka J; Liepinsh E; Makrecka-Kuka M; Liepins J; Cirule H; Gustina D; Loza E; Zharkova-Malkova O; Grinberga S; Pugovics O; Dambrova M Life Sci; 2014 Nov; 117(2):84-92. PubMed ID: 25301199 [TBL] [Abstract][Full Text] [Related]
18. Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development. Simó C; García-Cañas V Food Funct; 2020 Aug; 11(8):6745-6776. PubMed ID: 32686802 [TBL] [Abstract][Full Text] [Related]
19. Effects of dietary choline, betaine, and L-carnitine on the generation of trimethylamine-N-oxide in healthy mice. Yu ZL; Zhang LY; Jiang XM; Xue CH; Chi N; Zhang TT; Wang YM J Food Sci; 2020 Jul; 85(7):2207-2215. PubMed ID: 32572979 [TBL] [Abstract][Full Text] [Related]
20. Trimethylamine Canyelles M; Tondo M; Cedó L; Farràs M; Escolà-Gil JC; Blanco-Vaca F Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]